Submitted by Anonymous (not verified) on 1 August 2025 - 13:35
Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 8, Status: Authorised